Showing results (41-50 of 310) with videos related to
Sort By:
Pageof 31
Regulatory Toxicology and Pharmacology : RTP|January 27, 1998
Public health guidance values for chemical mixtures: current practice and future directionsH R Pohl, H Hansen, C H ChouResearch Communications in Chemical Pathology and Pharmacology|October 1, 1976
Warfarin: stereochemical aspects of its metabolism in vivo in the ratL R Pohl, R Bales, W F TragerAnxiety|January 1, 1994
Lactate-induced anxiety after imipramine and diazepam treatmentR Pohl, R Balon, R Berchou, et al.Regulatory Toxicology and Pharmacology : RTP|June 1, 2005
Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effectsHana R Pohl, Bryan Luukinen, James S HollerChemical Research in Toxicology|May 12, 2011
Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injuryMohammed Bourdi, John S Davies, Lance R PohlMetal Ions in Life Sciences|April 9, 2011
Mixtures and their risk assessment in toxicologyMoiz M Mumtaz, Hugh Hansen, Hana R PohlThe American Journal of Tropical Medicine and Hygiene|November 1, 1986
Giardia lamblia: a culture method for determining parasite viabilityD R Hill, R Pohl, R D PearsonRegulatory Toxicology and Pharmacology : RTP|May 5, 2005
Health effects classification and its role in the derivation of minimal risk levels: hepatic effectsHana R Pohl, C-H Selene J ChouRegulatory Toxicology and Pharmacology : RTP|June 1, 2005
Health effects classification and its role in the derivation of minimal risk levels: renal effectsC-H Selene J Chou, Hana R PohlRegulatory Toxicology and Pharmacology : RTP|October 24, 1998
Health effects classification and its role in the derivation of minimal risk levels: developmental effectsH R Pohl, C Smith-Simon, H HicksPageof 31